Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02133469Completed
Randomised, open-label trial of pneumococcal 7-valent conjugate vaccine in pneumococcal disease (2 arms), sponsored by Centers for Disease Control and Prevention. Primary endpoint: Carriage Rate of Vaccine-Serotype S. pneumoniae at 180 days after vaccination. Started Jun 2012; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02133469.